CD3+ and CD8+ cells are associated with a favourable outcome [40] and FoxP3+ cells, although a marker of the immunosuppressive regulatory T‐cells (Tregs), have also been reported to associate with better patient survival in CRC [41]. Here, FOXP3 is linked to colorectal carcinoma.